Have we witnessed the rise and fall of race-specific drugs?
作者信息
Coons Stephen Joel
出版信息
Clin Ther. 2009 Mar;31(3):620-2. doi: 10.1016/j.clinthera.2009.03.022.
Abstract
摘要
相似文献
1
Have we witnessed the rise and fall of race-specific drugs?
Clin Ther. 2009 Mar;31(3):620-2. doi: 10.1016/j.clinthera.2009.03.022.
2
Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Clin Ther. 2009 Mar;31(3):632-43. doi: 10.1016/j.clinthera.2009.03.019.
3
Dilemmas With Race and Heart Failure Treatment.
Circ Heart Fail. 2016 Oct;9(10). doi: 10.1161/CIRCHEARTFAILURE.116.003384.
4
Color blind, or just plain blind?
Altern Med Rev. 2005 Jun;10(2):81-2.
5
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
J Am Heart Assoc. 2013 Aug 21;2(4):e000214. doi: 10.1161/JAHA.113.000214.
6
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8.
7
Isosorbide dinitrate and hydralazine in blacks with heart failure.
N Engl J Med. 2005 Mar 10;352(10):1041-3; author reply 1041-3.
8
Race, drugs, and heart failure.
Geriatrics. 2005 Jul;60(7):8-9.
9
Race and a heart drug.
Minn Med. 2005 Mar;88(3):11.
10
Novel heart failure drug may offer options for you.
Heart Advis. 2005 Sep;8(9):2.
Zotero 插件